Phase II trial of oral aminopterin for adults and children with refractory acute leukemia.
Clin. Cancer Res., Nov;11(22):8089-96 (2005)
Marker turned target? A case to review neprilysin in ALL (or lessons learned at the American Association for Cancer Research Meetings, 2006).
J. Pediatr. Hematol. Oncol., Apr;28(4):201-2 (2006)
Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Ment Retard Dev Disabil Res Rev., 12(3):174-83 (2006)
What is learned from an acronym? Convergence of treatments and/or diseases?
J. Pediatr. Hematol. Oncol., May;29(5):277-8 (2007)
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol., Jun;62(1):65-75 (2008)
L'asparaginase and methotrexate combinations: clashes of empiric success and laboratory models?
J. Pediatr. Hematol. Oncol., Sep;29(9):587-8 (2007)
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cancer Chemother. Pharmacol., Aug;50(2):111-6 (2002)
Pharmacodynamic properties of methotrexate and Aminotrexate during weekly therapy.
Cancer Chemother. Pharmacol., Jun;57(6):826-34 (2006)
Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia.
Support Care Cancer., Dec;13(12):967-74 (2005)
Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance.
Cancer Res., Jun;61(11):4599-604 (2001)
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.
Cancer Chemother. Pharmacol., 26(5):343-4 (1990)
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia.
Cancer Chemother. Pharmacol., 30(2):155-7 (1992)
A Tribute and Salute to an Outstanding Colleague.
J. Pediatr. Hematol. Oncol., Mar;31(3):155-156 (2009)
Metronomic therapy from a pharmacologist's view.
J. Pediatr. Hematol. Oncol., Jun;28(6):325-7 (2006)
Megadose methylprednisolone therapy: 2 decades of experience and empiric success in need of explanation, validation, and exploitation.
J. Pediatr. Hematol. Oncol., Apr;29(4):211-2 (2007)
High-performance liquid chromatography separation of aminopterin-polyglutamates within red blood cells of children treated for acute lymphoblastic leukemia.
Transl Res., Dec;150(6):367-73 (2007)
High-dose methotrexate: insecure rationale: take 2.
J. Pediatr. Hematol. Oncol., Sep;30(9):639-40 (2008)
"The odds are all or none!" An account of one family's Odyssey more than a half century ago.
J. Pediatr. Hematol. Oncol., Jul;30(7):505-6 (2008)
A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro.
Adv. Drug Deliv. Rev., Apr;56(8):1085-97 (2004)
Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study.
Clin. Cancer Res., Feb;2(2):331-7 (1996)